Inceptionr LLC Allogene Therapeutics, Inc. Transaction History

Inceptionr LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.23 - $4.38 $49,633 - $97,485	-22,257 Reduced 66.8%	11,062 $25.8 Million
Q1 2024 May 09, 2024	BUY	$2.92 - $5.63 $97,291 - $187,585	33,319 New	33,319 $149 Million
Q2 2023 Aug 11, 2023	BUY	$4.53 - $6.74 $73,399 - $109,208	16,203 New	16,203 $80.5 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $11.11 $92,662 - $183,181	16,488 New	16,488 $104 Million

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

Stay updated on Inceptionr LLC with notifications on news.